Clozapine use in personality disorder and intellectual disability

Kiani, Reza, Biswas, Asit, Devapriam, John, Alexander, Regi Tharian, Kumar, Satheesh, Andrews, Hayley and Tromans, Samuel Joseph (2015) Clozapine use in personality disorder and intellectual disability. Advances in Mental Health and Intellectual Disabilities, 9 (6). pp. 363-370. ISSN 2044-1282

[thumbnail of Clozapine case series AMHID Table 1]
Preview
PDF (Clozapine case series AMHID Table 1) - Accepted Version
Download (9kB) | Preview
[thumbnail of Clozapine case series AMHID Table 2]
Preview
PDF (Clozapine case series AMHID Table 2) - Accepted Version
Download (87kB) | Preview
[thumbnail of Clozapine case series AMHID Anonymous Article File]
Preview
PDF (Clozapine case series AMHID Anonymous Article File) - Accepted Version
Download (225kB) | Preview

Abstract

Purpose: Clozapine is a well-known antipsychotic medication licensed for treatment-resistant schizophrenia, but there is limited research available to suggest its efficacy in the context of personality disorder and intellectual disabilities presenting with high-risk behaviour with or without psychotic symptoms. The purpose of this paper is to raise awareness of the benefits of using clozapine in patients with intellectual disabilities and personality disorder that present with a complex picture of serious risk of harm to both their life and the lives of others. Design/methodology/approach: The authors present five patients with intellectual disabilities and serious life-threatening challenging behaviour whom were started on clozapine as part of their multidisciplinary treatment plan to manage their presentation. The authors completed baseline assessment of five main symptom domains and then repeated this assessment following treatment with clozapine. Findings: In all five cases use of clozapine was objectively associated with an improvement in symptomatology, quality of life and a safe transfer to the community. Originality/value: The findings suggest that judicious use of clozapine could be considered as one of the effective pharmacological strategies in the management of patients with intellectual disabilities and personality disorder who present with serious life-threatening challenging behaviours.

Item Type: Article
Uncontrolled Keywords: intellectual disability,self-harm,antisocial,borderline personality disorder,clozapine,suicide risk,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 19 Dec 2015 07:13
Last Modified: 21 Oct 2022 01:16
URI: https://ueaeprints.uea.ac.uk/id/eprint/55777
DOI: 10.1108/AMHID-02-2015-0009

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item